Review



mouse mononuclear macrophage leukemia cell line  (Procell Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Procell Inc mouse mononuclear macrophage leukemia cell line
    Mouse Mononuclear Macrophage Leukemia Cell Line, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse mononuclear macrophage leukemia cell line/product/Procell Inc
    Average 86 stars, based on 1 article reviews
    mouse mononuclear macrophage leukemia cell line - by Bioz Stars, 2025-03
    86/100 stars

    Images



    Similar Products

    99
    ATCC mouse mononuclear macrophage leukemia cell line raw264 7
    Mouse Mononuclear Macrophage Leukemia Cell Line Raw264 7, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse mononuclear macrophage leukemia cell line raw264 7/product/ATCC
    Average 99 stars, based on 1 article reviews
    mouse mononuclear macrophage leukemia cell line raw264 7 - by Bioz Stars, 2025-03
    99/100 stars
      Buy from Supplier

    86
    Thermo Fisher mouse mononuclear macrophage leukemia cell line raw264 7
    Cell uptake and targeting capacity of MP NPs. ( A ) Representative fluorescence images of RD@P and RD@PM internalized by <t>RAW264.7</t> cells. ( B ) FACS results of cellular uptake of RD@P and RD @PM in RAW264.7 cells. ( C ) Quantification of cellular uptake of RD@P and RD@PM in RAW264.7 cells (n = 3, ∗∗ p < 0.01). ( D ) The experimental scheme of drug targeting in vivo in the implant infection model. Representative ex vivo fluorescence images ( E ) and quantification analysis ( F ) for PBS, free RD, RD@P, and RD@PM accumulation in the silicone sheets and major organs of IAI mice at 24 h after intravenous injection (n = 3, ∗∗ p < 0.01).
    Mouse Mononuclear Macrophage Leukemia Cell Line Raw264 7, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse mononuclear macrophage leukemia cell line raw264 7/product/Thermo Fisher
    Average 86 stars, based on 1 article reviews
    mouse mononuclear macrophage leukemia cell line raw264 7 - by Bioz Stars, 2025-03
    86/100 stars
      Buy from Supplier

    86
    Procell Inc mouse mononuclear macrophage leukemia cell line
    Cell uptake and targeting capacity of MP NPs. ( A ) Representative fluorescence images of RD@P and RD@PM internalized by <t>RAW264.7</t> cells. ( B ) FACS results of cellular uptake of RD@P and RD @PM in RAW264.7 cells. ( C ) Quantification of cellular uptake of RD@P and RD@PM in RAW264.7 cells (n = 3, ∗∗ p < 0.01). ( D ) The experimental scheme of drug targeting in vivo in the implant infection model. Representative ex vivo fluorescence images ( E ) and quantification analysis ( F ) for PBS, free RD, RD@P, and RD@PM accumulation in the silicone sheets and major organs of IAI mice at 24 h after intravenous injection (n = 3, ∗∗ p < 0.01).
    Mouse Mononuclear Macrophage Leukemia Cell Line, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse mononuclear macrophage leukemia cell line/product/Procell Inc
    Average 86 stars, based on 1 article reviews
    mouse mononuclear macrophage leukemia cell line - by Bioz Stars, 2025-03
    86/100 stars
      Buy from Supplier

    86
    Cell Biolabs Inc mouse mononuclear macrophage leukemia cell line raw 264 7
    Cell uptake and targeting capacity of MP NPs. ( A ) Representative fluorescence images of RD@P and RD@PM internalized by <t>RAW264.7</t> cells. ( B ) FACS results of cellular uptake of RD@P and RD @PM in RAW264.7 cells. ( C ) Quantification of cellular uptake of RD@P and RD@PM in RAW264.7 cells (n = 3, ∗∗ p < 0.01). ( D ) The experimental scheme of drug targeting in vivo in the implant infection model. Representative ex vivo fluorescence images ( E ) and quantification analysis ( F ) for PBS, free RD, RD@P, and RD@PM accumulation in the silicone sheets and major organs of IAI mice at 24 h after intravenous injection (n = 3, ∗∗ p < 0.01).
    Mouse Mononuclear Macrophage Leukemia Cell Line Raw 264 7, supplied by Cell Biolabs Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse mononuclear macrophage leukemia cell line raw 264 7/product/Cell Biolabs Inc
    Average 86 stars, based on 1 article reviews
    mouse mononuclear macrophage leukemia cell line raw 264 7 - by Bioz Stars, 2025-03
    86/100 stars
      Buy from Supplier

    Image Search Results


    Cell uptake and targeting capacity of MP NPs. ( A ) Representative fluorescence images of RD@P and RD@PM internalized by RAW264.7 cells. ( B ) FACS results of cellular uptake of RD@P and RD @PM in RAW264.7 cells. ( C ) Quantification of cellular uptake of RD@P and RD@PM in RAW264.7 cells (n = 3, ∗∗ p < 0.01). ( D ) The experimental scheme of drug targeting in vivo in the implant infection model. Representative ex vivo fluorescence images ( E ) and quantification analysis ( F ) for PBS, free RD, RD@P, and RD@PM accumulation in the silicone sheets and major organs of IAI mice at 24 h after intravenous injection (n = 3, ∗∗ p < 0.01).

    Journal: Materials Today Bio

    Article Title: A macrophage-like biomimetic nanoparticle with high-efficiency biofilm disruption and innate immunity activation for implant-related infection therapy

    doi: 10.1016/j.mtbio.2025.101575

    Figure Lengend Snippet: Cell uptake and targeting capacity of MP NPs. ( A ) Representative fluorescence images of RD@P and RD@PM internalized by RAW264.7 cells. ( B ) FACS results of cellular uptake of RD@P and RD @PM in RAW264.7 cells. ( C ) Quantification of cellular uptake of RD@P and RD@PM in RAW264.7 cells (n = 3, ∗∗ p < 0.01). ( D ) The experimental scheme of drug targeting in vivo in the implant infection model. Representative ex vivo fluorescence images ( E ) and quantification analysis ( F ) for PBS, free RD, RD@P, and RD@PM accumulation in the silicone sheets and major organs of IAI mice at 24 h after intravenous injection (n = 3, ∗∗ p < 0.01).

    Article Snippet: Mouse mononuclear macrophage leukemia cell line RAW264.7 and human umbilical vein endothelial cells line (HUVEC) were obtained from Southwest Jiaotong University (Chengdu, China) and cultured in DMEM high glucose medium and F12 medium, respectively, both of which contained 10 % FBS, at 37 °C in a 5 % CO 2 humidified environment incubator (Thermo Scientific, Sunnyvale, CA).

    Techniques: Fluorescence, In Vivo, Infection, Ex Vivo, Injection

    Immunomodulatory effects of F/R@PM on macrophages in vitro. ( A ) Typical scatter plots of macrophage surface markers CD86 (M1 macrophage marker) as detected using a flow cytometer. ( B ) Representative western blot results of the expression of CD86 protein after various treatments. ( C ) Corresponding quantitative analyses of western blot results (n = 3, ∗∗ P < 0.01). ( D ) ELISA results of cytokines (TNF- α and IL-6) secreted by RAW264.7 in different groups (n = 3, ∗∗ P < 0.01). ( E ) Counted results of phagocytized S. aureus by RAW264.7 treated in different conditions (n = 3, ∗∗ P < 0.01). ( F ) Swallowed S. aureus was observed by using TEM. Yellow arrows indicate S. aureus . (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

    Journal: Materials Today Bio

    Article Title: A macrophage-like biomimetic nanoparticle with high-efficiency biofilm disruption and innate immunity activation for implant-related infection therapy

    doi: 10.1016/j.mtbio.2025.101575

    Figure Lengend Snippet: Immunomodulatory effects of F/R@PM on macrophages in vitro. ( A ) Typical scatter plots of macrophage surface markers CD86 (M1 macrophage marker) as detected using a flow cytometer. ( B ) Representative western blot results of the expression of CD86 protein after various treatments. ( C ) Corresponding quantitative analyses of western blot results (n = 3, ∗∗ P < 0.01). ( D ) ELISA results of cytokines (TNF- α and IL-6) secreted by RAW264.7 in different groups (n = 3, ∗∗ P < 0.01). ( E ) Counted results of phagocytized S. aureus by RAW264.7 treated in different conditions (n = 3, ∗∗ P < 0.01). ( F ) Swallowed S. aureus was observed by using TEM. Yellow arrows indicate S. aureus . (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

    Article Snippet: Mouse mononuclear macrophage leukemia cell line RAW264.7 and human umbilical vein endothelial cells line (HUVEC) were obtained from Southwest Jiaotong University (Chengdu, China) and cultured in DMEM high glucose medium and F12 medium, respectively, both of which contained 10 % FBS, at 37 °C in a 5 % CO 2 humidified environment incubator (Thermo Scientific, Sunnyvale, CA).

    Techniques: In Vitro, Marker, Flow Cytometry, Western Blot, Expressing, Enzyme-linked Immunosorbent Assay